Pharmaceutical Contract Manufacturing And Research Services Market Size, Share & Trends Analysis Report By Service (Manufacturing, Research), By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 72 Business Hours
Pharmaceutical Contract Manufacturing And Research Services Market Growth & Trends
The global pharmaceutical contract manufacturing and research services market size is expected to reach USD 395.2 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.2% from 2022 to 2030. The rising investments in R&D, increasing demand for generics, and the growing aging population with various chronic diseases are responsible for market growth. However, the advent of COVID-19 led to a temporary shutdown of research and manufacturing activities of ancillary goods used for manufacturing drugs, which had impacted the supply chain and is likely to have a negative impact on the market growth.
Outsourcing allows pharmaceutical companies to focus on their core competencies such as sales and marketing rather than manufacturing and research. This is expected to have a positive impact on the market growth. However, the pharmaceutical companies practicing in-house manufacturing are increasing their investments with respect to production capabilities. This may limit the potential growth of contract manufacturing services to traditional customers, thereby hampering industrial growth.
The COVID-19 pandemic has provided new opportunities for pharmaceutical contract manufacturing and research services. Because of this pandemic, the contract service sector has switched its focus toward manufacturing and research of COVID-19 therapies and vaccines. For instance, in October 2020, CDMO Recipharm formed an agreement with Arcturus Therapeutics to support the manufacturing of its COVID-19 vaccine candidate—ARCT-021. Currently, it is in the phase 1/2 clinical trial. Similarly, in March 2022, the biotechnology company GeoVax partnered with a CRO CATO SMS to support GeoVAX in the Phase 2 trials of the COVID-19 Vaccine candidate GEO-CM04S1.
Pharmaceutical Contract Manufacturing And Research Services Market Report Highlights
Pharmaceutical Contract Manufacturing And Research Services Market Growth & Trends
The global pharmaceutical contract manufacturing and research services market size is expected to reach USD 395.2 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.2% from 2022 to 2030. The rising investments in R&D, increasing demand for generics, and the growing aging population with various chronic diseases are responsible for market growth. However, the advent of COVID-19 led to a temporary shutdown of research and manufacturing activities of ancillary goods used for manufacturing drugs, which had impacted the supply chain and is likely to have a negative impact on the market growth.
Outsourcing allows pharmaceutical companies to focus on their core competencies such as sales and marketing rather than manufacturing and research. This is expected to have a positive impact on the market growth. However, the pharmaceutical companies practicing in-house manufacturing are increasing their investments with respect to production capabilities. This may limit the potential growth of contract manufacturing services to traditional customers, thereby hampering industrial growth.
The COVID-19 pandemic has provided new opportunities for pharmaceutical contract manufacturing and research services. Because of this pandemic, the contract service sector has switched its focus toward manufacturing and research of COVID-19 therapies and vaccines. For instance, in October 2020, CDMO Recipharm formed an agreement with Arcturus Therapeutics to support the manufacturing of its COVID-19 vaccine candidate—ARCT-021. Currently, it is in the phase 1/2 clinical trial. Similarly, in March 2022, the biotechnology company GeoVax partnered with a CRO CATO SMS to support GeoVAX in the Phase 2 trials of the COVID-19 Vaccine candidate GEO-CM04S1.
Pharmaceutical Contract Manufacturing And Research Services Market Report Highlights
- By service, the manufacturing segment dominated the market in 2021. In this segment, Active Pharmaceutical Ingredient (API) / bulk drugs held the largest revenue share of over 60.0% in 2021. Pharmaceutical companies prefer outsourcing services for API research and manufacturing owing to the reduction in the cost of production of APIs
- In the manufacturing service segment, finished dose formulations are expected to register the fastest CAGR of 7.7% from 2022 to 2030
- The research service segment is further segmented based on therapeutic area, wherein oncology held a significant share of over 25.0% in 2021 and is anticipated to maintain its lead in the coming years owing to the high disease burden of cancer worldwide
- CMOs/CDMOs with the ability to establish facilities in emerging countries are expected to drive the market. The contract service sector is in its infancy in countries, including Brazil, India, and China
- Companies can position themselves for strong growth, given that demand is expected to expand rapidly in the coming years. Increased competitiveness in the contract service sector is anticipated to ultimately benefit the sector growth
- China, Japan, and India are projected to witness tremendous growth in the forecast period owing to high disease prevalence
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation & Scope
1.1.1 Service
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Volume Price Analysis (Model 2)
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective -
1.10.2 Objective -
1.10.3 Objective -
1.10.4 Objective -
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
CHAPTER 3 PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH MARKET: VARIABLES, TRENDS, & SCOPE
3.1 Market Segmentation and Scope
3.2 Market Driver Analysis
3.2.1 Drug shortage driving demand for pharmaceutical development
3.2.2 Commercial success of biologics for clinical use
3.2.3 Lower manufacturing costs and improving economic condition of BRIC
3.3 Market Restraint Analysis
3.3.1 Limited outsourcing opted by big pharma companies
3.3.2 Regulatory issues pertaining to the drug approval
3.4 Penetration & Growth Prospect Mapping
3.5 Porter’s Five Forces Analysis
3.6 PESTEL Analysis
3.7 COVID-19 Analysis
CHAPTER 4 PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH MARKET: SERVICES SEGMENT ANALYSIS
5.1 Pharmaceutical Contract Manufacturing & Research Market: Market Share Analysis, 2021 & 2030
5.2 Manufacturing
5.2.1 Manufacturing market, 2018 - 2030 (USD Billion)
5.2.2 API/Bulk Drugs
5.2.2.1 API/Bulk Drugs market, 2018 - 2030 (USD Billion)
5.2.3 Advanced Drug Delivery Formulations
5.2.3.1 Advanced Drug Delivery Formulations market, 2018 - 2030 (USD Billion)
5.2.4 Packaging
5.2.4.1 packaging market, 2018 - 2030 (USD Billion)
5.2.5 Finished Dose Formulations
5.2.5.1 Finished Dose Formulations market, 2018 - 2030 (USD Billion)
5.2.5.2 Solid
5.2.5.2.1 Solid market, 2018 - 2030 (USD Billion)
5.2.5.3 Liquid
5.2.5.3.1 Liquid market, 2018 - 2030 (USD Billion)
5.2.5.4 Semi-solid formulations
5.2.5.4.1 Semi-solid formulations market, 2018 - 2030 (USD Billion)
5.3 Research
5.3.1 Research market, 2018 - 2030 (USD Billion)
5.3.2 Oncology
5.3.2.1 Oncology market, 2018 - 2030 (USD Billion)
5.3.3 Vaccines
5.3.3.1 Vaccines market, 2018 - 2030 (USD Billion)
5.3.4 Inflammation & Immunology
5.3.4.1 Inflammation & Immunology market, 2018 - 2030 (USD Billion)
5.3.5 Cardiology
5.3.5.1 Cardiology market, 2018 - 2030 (USD Billion)
5.3.6 Neuroscience
5.3.6.1 Neuroscience market, 2018 - 2030 (USD Billion)
5.3.7 Others
5.3.7.1 Others market, 2018 - 2030 (USD Billion)
CHAPTER 6 PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH MARKET: REGIONAL ANALYSIS
6.1 Pharmaceutical Contract Manufacturing & Research Market: Market Share Analysis, 2021 & 2030
6.2 North America
6.2.1 North America Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.2.2 U.S.
6.2.2.1 U.S. Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.2.3 Canada
6.2.3.1 Canada Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.3 Europe
6.3.1 Europe Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.3.2 Germany
6.3.2.1 Germany Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.3.3 France
6.3.3.1 France Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.3.4 Italy
6.3.4.1 Italy Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.3.5 Spain
6.3.5.1 Spain Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.3.6 U.K.
6.3.6.1 U.K. Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.4 Asia Pacific
6.4.1 Asia Pacific Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.4.2 China
6.4.2.1 China Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.4.3 India
6.4.3.1 India Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.4.4 Japan
6.4.4.1 Japan Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.4.5 Australia
6.4.5.1 Australia Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.5 Latin America
6.5.1 Latin America Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.5.2 Brazil
6.5.2.1 Brazil Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.5.3 Mexico
6.5.3.1 Mexico Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.5.4 Argentina
6.5.4.1 Argentina Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.5.5 Colombia
6.5.5.1 Colombia Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.5.6 Chile
6.5.6.1 Chile Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.5.7 VENEZUELA
6.5.7.1 venezuela Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.6 MEA
6.6.1 MEA Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.6.2 South Africa
6.6.2.1 South Africa Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.6.3 Saudi Arabia
6.6.3.1 Saudi Arabia Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
CHAPTER 7 COMPETITIVE LANDSCAPE
7.1 Strategy Framework
7.2 Market Participation Categorization
7.3 Company Profiles
7.3.1 Boehringer Ingelheim GmbH
7.3.1.1 Company overview
7.3.1.2 Financial performance
7.3.1.3 Product benchmarking
7.3.1.4 Strategic initiatives
7.3.2 Lonza
7.3.2.1 Company overview
7.3.2.2 Financial performance
7.3.2.3 Product benchmarking
7.3.2.4 Strategic initiatives
7.3.3 Grifols S.A
7.3.3.1 Company overview
7.3.3.2 Financial performance
7.3.3.3 Product benchmarking
7.3.3.4 Strategic initiatives
7.3.4 Jubilant Life Sciences Limited
7.3.4.1 Company overview
7.3.4.2 Financial performance
7.3.4.3 Product benchmarking
7.3.4.4 Strategic initiatives
7.3.5 Pfizer, Inc.
7.3.5.1 Company overview
7.3.5.2 Financial performance
7.3.5.3 Product benchmarking
7.3.5.4 Strategic initiatives
7.3.6 Charles River Laboratories International, Inc
7.3.6.1 Company overview
7.3.6.2 Financial performance
7.3.6.3 Product benchmarking
7.3.6.4 Strategic initiatives
7.3.7 Albany Molecular Research, Inc.
7.3.7.1 Company overview
7.3.7.2 Product benchmarking
7.3.7.3 Strategic initiatives
7.3.8 Covance, Inc. (LabCorp)
7.3.8.1 Company overview
7.3.8.2 Financial performance
7.3.8.3 Product benchmarking
7.3.9 IQVIA
7.3.9.1 Company overview
7.3.9.2 Financial performance
7.3.9.3 Product benchmarking
7.3.9.4 Strategic initiatives
7.3.10 Baxter BioPharma Solutions
7.3.10.1 Company overview
7.3.10.2 Financial performance
7.3.10.3 Product Benchmarking
7.3.10.4 Strategic initiatives
7.3.11 Aenova Holding GmbH
7.3.11.1 Company overview
7.3.11.2 Product Benchmarking
7.3.12 Vetter Pharma
7.3.12.1 Company Overview
7.3.12.2 Product benchmarking
7.3.13 Valeant Pharmaceuticals International Inc.
7.3.13.1 Company Overview
7.3.13.2 Financial performance
7.3.13.3 Product benchmarking
7.3.14 Ligand Pharmaceuticals, Inc.
7.3.14.1 Company Overview
7.3.14.2 Financial performance
7.3.14.3 Product benchmarking
7.3.14.4 Strategic initiatives
7.3.15 Pharmaceutical Product Development, LLC
7.3.15.1 Company Overview
7.3.15.2 Financial performance
7.3.15.3 Product benchmarking
7.3.15.4 Strategic initiatives
7.3.16 Recipharm AB.
7.3.16.1 Company Overview
7.3.16.2 Financial performance
7.3.16.3 Product benchmarking
7.3.16.4 Strategic initiatives
7.3.17 AbbVie, Inc.
7.3.17.1 Company Overview
7.3.17.2 Financial performance
7.3.17.3 Product benchmarking
7.3.17.4 Strategic initiatives
7.3.18 Famar Health Care Services
7.3.18.1 Company Overview
7.3.18.2 Product benchmarking
7.3.18.3 Strategic initiatives
7.3.19 Catalent Pharma Solutions
7.3.19.1 Company Overview
7.3.19.2 Financial performance
7.3.19.3 Product benchmarking
7.3.19.4 Strategic initiatives
7.3.20 West Pharmaceutical Services, Inc.
7.3.20.1 Company Overview
7.3.20.2 Financial performance
7.3.20.3 Product benchmarking
7.3.20.4 Strategic initiatives
1.1 Market Segmentation & Scope
1.1.1 Service
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Volume Price Analysis (Model 2)
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective -
1.10.2 Objective -
1.10.3 Objective -
1.10.4 Objective -
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
CHAPTER 3 PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH MARKET: VARIABLES, TRENDS, & SCOPE
3.1 Market Segmentation and Scope
3.2 Market Driver Analysis
3.2.1 Drug shortage driving demand for pharmaceutical development
3.2.2 Commercial success of biologics for clinical use
3.2.3 Lower manufacturing costs and improving economic condition of BRIC
3.3 Market Restraint Analysis
3.3.1 Limited outsourcing opted by big pharma companies
3.3.2 Regulatory issues pertaining to the drug approval
3.4 Penetration & Growth Prospect Mapping
3.5 Porter’s Five Forces Analysis
3.6 PESTEL Analysis
3.7 COVID-19 Analysis
CHAPTER 4 PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH MARKET: SERVICES SEGMENT ANALYSIS
5.1 Pharmaceutical Contract Manufacturing & Research Market: Market Share Analysis, 2021 & 2030
5.2 Manufacturing
5.2.1 Manufacturing market, 2018 - 2030 (USD Billion)
5.2.2 API/Bulk Drugs
5.2.2.1 API/Bulk Drugs market, 2018 - 2030 (USD Billion)
5.2.3 Advanced Drug Delivery Formulations
5.2.3.1 Advanced Drug Delivery Formulations market, 2018 - 2030 (USD Billion)
5.2.4 Packaging
5.2.4.1 packaging market, 2018 - 2030 (USD Billion)
5.2.5 Finished Dose Formulations
5.2.5.1 Finished Dose Formulations market, 2018 - 2030 (USD Billion)
5.2.5.2 Solid
5.2.5.2.1 Solid market, 2018 - 2030 (USD Billion)
5.2.5.3 Liquid
5.2.5.3.1 Liquid market, 2018 - 2030 (USD Billion)
5.2.5.4 Semi-solid formulations
5.2.5.4.1 Semi-solid formulations market, 2018 - 2030 (USD Billion)
5.3 Research
5.3.1 Research market, 2018 - 2030 (USD Billion)
5.3.2 Oncology
5.3.2.1 Oncology market, 2018 - 2030 (USD Billion)
5.3.3 Vaccines
5.3.3.1 Vaccines market, 2018 - 2030 (USD Billion)
5.3.4 Inflammation & Immunology
5.3.4.1 Inflammation & Immunology market, 2018 - 2030 (USD Billion)
5.3.5 Cardiology
5.3.5.1 Cardiology market, 2018 - 2030 (USD Billion)
5.3.6 Neuroscience
5.3.6.1 Neuroscience market, 2018 - 2030 (USD Billion)
5.3.7 Others
5.3.7.1 Others market, 2018 - 2030 (USD Billion)
CHAPTER 6 PHARMACEUTICAL CONTRACT MANUFACTURING & RESEARCH MARKET: REGIONAL ANALYSIS
6.1 Pharmaceutical Contract Manufacturing & Research Market: Market Share Analysis, 2021 & 2030
6.2 North America
6.2.1 North America Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.2.2 U.S.
6.2.2.1 U.S. Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.2.3 Canada
6.2.3.1 Canada Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.3 Europe
6.3.1 Europe Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.3.2 Germany
6.3.2.1 Germany Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.3.3 France
6.3.3.1 France Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.3.4 Italy
6.3.4.1 Italy Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.3.5 Spain
6.3.5.1 Spain Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.3.6 U.K.
6.3.6.1 U.K. Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.4 Asia Pacific
6.4.1 Asia Pacific Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.4.2 China
6.4.2.1 China Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.4.3 India
6.4.3.1 India Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.4.4 Japan
6.4.4.1 Japan Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.4.5 Australia
6.4.5.1 Australia Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.5 Latin America
6.5.1 Latin America Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.5.2 Brazil
6.5.2.1 Brazil Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.5.3 Mexico
6.5.3.1 Mexico Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.5.4 Argentina
6.5.4.1 Argentina Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.5.5 Colombia
6.5.5.1 Colombia Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.5.6 Chile
6.5.6.1 Chile Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.5.7 VENEZUELA
6.5.7.1 venezuela Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.6 MEA
6.6.1 MEA Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.6.2 South Africa
6.6.2.1 South Africa Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
6.6.3 Saudi Arabia
6.6.3.1 Saudi Arabia Pharmaceutical Contract Manufacturing & Research Market, 2018 - 2030 (USD Billion)
CHAPTER 7 COMPETITIVE LANDSCAPE
7.1 Strategy Framework
7.2 Market Participation Categorization
7.3 Company Profiles
7.3.1 Boehringer Ingelheim GmbH
7.3.1.1 Company overview
7.3.1.2 Financial performance
7.3.1.3 Product benchmarking
7.3.1.4 Strategic initiatives
7.3.2 Lonza
7.3.2.1 Company overview
7.3.2.2 Financial performance
7.3.2.3 Product benchmarking
7.3.2.4 Strategic initiatives
7.3.3 Grifols S.A
7.3.3.1 Company overview
7.3.3.2 Financial performance
7.3.3.3 Product benchmarking
7.3.3.4 Strategic initiatives
7.3.4 Jubilant Life Sciences Limited
7.3.4.1 Company overview
7.3.4.2 Financial performance
7.3.4.3 Product benchmarking
7.3.4.4 Strategic initiatives
7.3.5 Pfizer, Inc.
7.3.5.1 Company overview
7.3.5.2 Financial performance
7.3.5.3 Product benchmarking
7.3.5.4 Strategic initiatives
7.3.6 Charles River Laboratories International, Inc
7.3.6.1 Company overview
7.3.6.2 Financial performance
7.3.6.3 Product benchmarking
7.3.6.4 Strategic initiatives
7.3.7 Albany Molecular Research, Inc.
7.3.7.1 Company overview
7.3.7.2 Product benchmarking
7.3.7.3 Strategic initiatives
7.3.8 Covance, Inc. (LabCorp)
7.3.8.1 Company overview
7.3.8.2 Financial performance
7.3.8.3 Product benchmarking
7.3.9 IQVIA
7.3.9.1 Company overview
7.3.9.2 Financial performance
7.3.9.3 Product benchmarking
7.3.9.4 Strategic initiatives
7.3.10 Baxter BioPharma Solutions
7.3.10.1 Company overview
7.3.10.2 Financial performance
7.3.10.3 Product Benchmarking
7.3.10.4 Strategic initiatives
7.3.11 Aenova Holding GmbH
7.3.11.1 Company overview
7.3.11.2 Product Benchmarking
7.3.12 Vetter Pharma
7.3.12.1 Company Overview
7.3.12.2 Product benchmarking
7.3.13 Valeant Pharmaceuticals International Inc.
7.3.13.1 Company Overview
7.3.13.2 Financial performance
7.3.13.3 Product benchmarking
7.3.14 Ligand Pharmaceuticals, Inc.
7.3.14.1 Company Overview
7.3.14.2 Financial performance
7.3.14.3 Product benchmarking
7.3.14.4 Strategic initiatives
7.3.15 Pharmaceutical Product Development, LLC
7.3.15.1 Company Overview
7.3.15.2 Financial performance
7.3.15.3 Product benchmarking
7.3.15.4 Strategic initiatives
7.3.16 Recipharm AB.
7.3.16.1 Company Overview
7.3.16.2 Financial performance
7.3.16.3 Product benchmarking
7.3.16.4 Strategic initiatives
7.3.17 AbbVie, Inc.
7.3.17.1 Company Overview
7.3.17.2 Financial performance
7.3.17.3 Product benchmarking
7.3.17.4 Strategic initiatives
7.3.18 Famar Health Care Services
7.3.18.1 Company Overview
7.3.18.2 Product benchmarking
7.3.18.3 Strategic initiatives
7.3.19 Catalent Pharma Solutions
7.3.19.1 Company Overview
7.3.19.2 Financial performance
7.3.19.3 Product benchmarking
7.3.19.4 Strategic initiatives
7.3.20 West Pharmaceutical Services, Inc.
7.3.20.1 Company Overview
7.3.20.2 Financial performance
7.3.20.3 Product benchmarking
7.3.20.4 Strategic initiatives
LIST OF TABLES
TABLE 1 North America pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 2 North America manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 3 North America finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 4 North America research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 5 U.S. pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 6 U.S. manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 7 U.S. finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 8 U.S. research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 9 Canada pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 10 Canada manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 11 Canada finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 12 Canada research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 13 Europe pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 14 Europe manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 15 Europe finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 16 Europe research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 17 Germany pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 18 Germany manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 19 Germany finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 20 Germany research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 21 France pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 22 France manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 23 France finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 24 France research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 25 Italy pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 26 Italy manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 27 Italy finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 28 Italy research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 29 Spain pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 30 Spain manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 31 Spain finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 32 Spain research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 33 U.K. pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 34 U.K. manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 35 U.K. finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 36 U.K. research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 37 Asia Pacific pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 38 Asia Pacific manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 39 Asia Pacific finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 40 Asia Pacific research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 41 India pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 42 India manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 43 India finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 44 India research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 45 China pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 46 China manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 47 China finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 48 China research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 49 Japan pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 50 Japan manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 51 Japan finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 52 Japan research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 53 Australia pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 54 Australia manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 55 Australia finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 56 Australia research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 57 Latin America pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 58 Latin America manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 59 Latin America finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 60 Latin America research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 61 Brazil pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 62 Brazil manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 63 Brazil finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 64 Brazil research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 65 Mexico pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 66 Mexico manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 67 Mexico finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 68 Mexico research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 69 Colombia pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 70 Colombia manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 71 Colombia finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 72 Colombia research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 73 Argentina pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 74 Argentina manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 75 Argentina finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 76 Argentina research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 77 Chile pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 78 Chile manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 79 Chile finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 80 Chile research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 81 Venezuela pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 82 Venezuela manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 83 Venezuela finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 84 Venezuela research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 85 MEA pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 86 MEA manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 87 MEA finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 88 MEA research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 89 South Africa pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 90 South Africa manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 91 South Africa finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 92 South Africa research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 81 Saudi Arabia pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 82 Saudi Arabia manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 83 Saudi Arabia finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 84 Saudi Arabia research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 1 North America pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 2 North America manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 3 North America finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 4 North America research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 5 U.S. pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 6 U.S. manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 7 U.S. finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 8 U.S. research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 9 Canada pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 10 Canada manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 11 Canada finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 12 Canada research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 13 Europe pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 14 Europe manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 15 Europe finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 16 Europe research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 17 Germany pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 18 Germany manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 19 Germany finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 20 Germany research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 21 France pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 22 France manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 23 France finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 24 France research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 25 Italy pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 26 Italy manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 27 Italy finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 28 Italy research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 29 Spain pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 30 Spain manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 31 Spain finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 32 Spain research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 33 U.K. pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 34 U.K. manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 35 U.K. finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 36 U.K. research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 37 Asia Pacific pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 38 Asia Pacific manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 39 Asia Pacific finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 40 Asia Pacific research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 41 India pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 42 India manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 43 India finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 44 India research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 45 China pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 46 China manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 47 China finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 48 China research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 49 Japan pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 50 Japan manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 51 Japan finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 52 Japan research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 53 Australia pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 54 Australia manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 55 Australia finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 56 Australia research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 57 Latin America pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 58 Latin America manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 59 Latin America finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 60 Latin America research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 61 Brazil pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 62 Brazil manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 63 Brazil finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 64 Brazil research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 65 Mexico pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 66 Mexico manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 67 Mexico finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 68 Mexico research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 69 Colombia pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 70 Colombia manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 71 Colombia finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 72 Colombia research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 73 Argentina pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 74 Argentina manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 75 Argentina finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 76 Argentina research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 77 Chile pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 78 Chile manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 79 Chile finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 80 Chile research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 81 Venezuela pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 82 Venezuela manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 83 Venezuela finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 84 Venezuela research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 85 MEA pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 86 MEA manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 87 MEA finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 88 MEA research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 89 South Africa pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 90 South Africa manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 91 South Africa finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 92 South Africa research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 81 Saudi Arabia pharmaceutical contract manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 82 Saudi Arabia manufacturing & research services market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 83 Saudi Arabia finished dose formulations market forecasts, by service, 2018 - 2030 (USD Billion)
TABLE 84 Saudi Arabia research services market forecasts, by service, 2018 - 2030 (USD Billion)
LIST OF FIGURES
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (current & future impact)
FIG. 11 Factors playing role in drug shortfall
FIG. 12 Market restraint relevance analysis (current & future impact)
FIG. 13 Penetration & growth prospect mapping, 2016
FIG. 14 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 15 Porter’s Five Forces Analysis
FIG. 16 Pharmaceutical contract manufacturing & research services: Service outlook key takeaways
FIG. 17 Top five activities by average percentage of activity outsourced
FIG. 18 Pharmaceutical contract manufacturing & research services: Service movement analysis
FIG. 19 Survey study for outsourcing needs
FIG. 20 Pharmaceutical Contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 21 API/bulk drugs contract manufacturing market, 2018 - 2030 (USD Billion)
FIG. 22 Advanced drug delivery formulations market, 2018 - 2030 (USD Billion)
FIG. 23 Packaging contract services market, 2018 - 2030 (USD Billion)
FIG. 24 Finished dose formulations market, 2018 - 2030 (USD Billion)
FIG. 25 Solid finished dose formulations contract manufacturing market, 2018 - 2030 (USD Billion)
FIG. 26 Liquid formulations contract manufacturing market, 2018 - 2030 (USD Billion)
FIG. 27 Semi-solid formulations contract manufacturing market, 2018 - 2030 (USD Billion)
FIG. 28 Pharmaceutical Contract research services market, 2018 - 2030 (USD Billion)
FIG. 29 Oncology market, 2018 - 2030 (USD Billion)
FIG. 30 Vaccines market, 2018 - 2030 (USD Billion)
FIG. 31 Inflammation & immunology market, 2018 - 2030 (USD Billion)
FIG. 32 Cardiology market, 2018 - 2030 (USD Billion)
FIG. 33 Neuroscience market, 2018 - 2030 (USD Billion)
FIG. 34 Other research services market, 2018 - 2030 (USD Billion)
FIG. 35 Regional market place: Key takeaway
FIG. 36 Global pharmaceutical contract manufacturing & research services country outlook, 2021 & 2030
FIG. 37 North America pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 38 U.S. pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 39 Canada pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 40 Europe pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 41 Germany pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 42 France pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 43 Italy pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 44 Spain pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 45 U.K. pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 46 Asia Pacific pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 47 India pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 48 China pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 49 Japan pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 50 Australia pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 51 Latin America pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 52 Brazil pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 53 Mexico pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 54 Colombia pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 55 Argentina pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 56 Chile pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 57 Venezuela pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 58 MEA pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 59 South Africa pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 60 Saudi Arabia pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 61 Strategy framework
FIG. 62 Participant categorization
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (current & future impact)
FIG. 11 Factors playing role in drug shortfall
FIG. 12 Market restraint relevance analysis (current & future impact)
FIG. 13 Penetration & growth prospect mapping, 2016
FIG. 14 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 15 Porter’s Five Forces Analysis
FIG. 16 Pharmaceutical contract manufacturing & research services: Service outlook key takeaways
FIG. 17 Top five activities by average percentage of activity outsourced
FIG. 18 Pharmaceutical contract manufacturing & research services: Service movement analysis
FIG. 19 Survey study for outsourcing needs
FIG. 20 Pharmaceutical Contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 21 API/bulk drugs contract manufacturing market, 2018 - 2030 (USD Billion)
FIG. 22 Advanced drug delivery formulations market, 2018 - 2030 (USD Billion)
FIG. 23 Packaging contract services market, 2018 - 2030 (USD Billion)
FIG. 24 Finished dose formulations market, 2018 - 2030 (USD Billion)
FIG. 25 Solid finished dose formulations contract manufacturing market, 2018 - 2030 (USD Billion)
FIG. 26 Liquid formulations contract manufacturing market, 2018 - 2030 (USD Billion)
FIG. 27 Semi-solid formulations contract manufacturing market, 2018 - 2030 (USD Billion)
FIG. 28 Pharmaceutical Contract research services market, 2018 - 2030 (USD Billion)
FIG. 29 Oncology market, 2018 - 2030 (USD Billion)
FIG. 30 Vaccines market, 2018 - 2030 (USD Billion)
FIG. 31 Inflammation & immunology market, 2018 - 2030 (USD Billion)
FIG. 32 Cardiology market, 2018 - 2030 (USD Billion)
FIG. 33 Neuroscience market, 2018 - 2030 (USD Billion)
FIG. 34 Other research services market, 2018 - 2030 (USD Billion)
FIG. 35 Regional market place: Key takeaway
FIG. 36 Global pharmaceutical contract manufacturing & research services country outlook, 2021 & 2030
FIG. 37 North America pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 38 U.S. pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 39 Canada pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 40 Europe pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 41 Germany pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 42 France pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 43 Italy pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 44 Spain pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 45 U.K. pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 46 Asia Pacific pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 47 India pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 48 China pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 49 Japan pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 50 Australia pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 51 Latin America pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 52 Brazil pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 53 Mexico pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 54 Colombia pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 55 Argentina pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 56 Chile pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 57 Venezuela pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 58 MEA pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 59 South Africa pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 60 Saudi Arabia pharmaceutical contract manufacturing & research services market, 2018 - 2030 (USD Billion)
FIG. 61 Strategy framework
FIG. 62 Participant categorization
